Patents by Inventor Asya Rolls

Asya Rolls has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338741
    Abstract: The present invention is directed to a method for treating a bowel disease in a subject in need thereof, the method comprising inhibiting the activity of neurons of the insular cortex of the subject. Further provided is a system comprising a transcranial stimulation transducing coil for transcranial stimulation configured to provide a series of pulses to neurons of the insular cortex.
    Type: Application
    Filed: June 27, 2023
    Publication date: October 26, 2023
    Inventors: Asya ROLLS, Tamar KOREN, Hilla AZULAY-DEBBY, Tamar BEN SHAANAN
  • Patent number: 11724119
    Abstract: The present invention is directed to a method for treating a bowel disease in a subject in need thereof, the method comprising inhibiting the activity of neurons of the insular cortex of the subject. Further provided is a system comprising a transcranial stimulation transducing coil for transcranial stimulation configured to provide a series of pulses to neurons of the insular cortex.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: August 15, 2023
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Asya Rolls, Tamar Koren, Hilla Azulay-Debby, Tamar Ben Shaanan
  • Publication number: 20230037897
    Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.
    Type: Application
    Filed: September 19, 2022
    Publication date: February 9, 2023
    Inventors: Asya ROLLS, Tamar BEN SHANNAN, Hilla AZULAY-DEBBIE, Fahed HAKIM, Maya SCHILLER, Shai SHEN-ORR, Elina STAROSVETSKY
  • Patent number: 11471453
    Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: October 18, 2022
    Assignees: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, HEALTH CORPORATION - RAMBAM
    Inventors: Asya Rolls, Tamar Ben Shannan, Hilla Azulay-Debbie, Fahed Hakim, Maya Schiller, Shai Shen-Orr, Elina Starosvetsky
  • Publication number: 20220151542
    Abstract: The present invention is directed to a method for inducing an immune response in a subject, including a step of activating neurons in the mesolimbic network of the subject by applying a neurofeedback.
    Type: Application
    Filed: March 3, 2020
    Publication date: May 19, 2022
    Inventors: Talma HENDLER, Asya ROLLS, Nitzan LUBIANIKER, Tamar KOREN, Neomi SINGER, Tamar BEN SHANNAN, Shai SHEN ORR, Fahed HAKIM, Hilla AZULAY DEBBY, Rani COHEN
  • Publication number: 20210046324
    Abstract: The present invention is directed to a method for treating a bowel disease in a subject in need thereof, the method comprising inhibiting the activity of neurons of the insular cortex of the subject. Further provided is a system comprising a transcranial stimulation transducing coil for transcranial stimulation configured to provide a series of pulses to neurons of the insular cortex.
    Type: Application
    Filed: December 6, 2018
    Publication date: February 18, 2021
    Inventors: Asya ROLLS, Tamar KOREN, Hilla AZULAY-DEBBY, Tamar BEN SHAANAN
  • Publication number: 20200376287
    Abstract: The present invention, in some embodiments thereof, is directed to a method for preserving or promoting oral tolerance in a subject in need thereof, including modulating neurons in the mid-posterior region of the insular cortex (mpIC). Further provided is a method for increasing TGF-? signaling in a subject in need thereof.
    Type: Application
    Filed: May 28, 2020
    Publication date: December 3, 2020
    Inventors: Asya ROLLS, Maria KROT, Hilla AZULAY-DEBBY
  • Publication number: 20200246329
    Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.
    Type: Application
    Filed: March 30, 2020
    Publication date: August 6, 2020
    Inventors: Asya ROLLS, Tamar BEN SHANNAN, Hilla AZULAY-DEBBIE, Fahed HAKIM, Maya SCHILLER, Shai SHEN-ORR, Elina STAROSVETSKY
  • Patent number: 10603315
    Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: March 31, 2020
    Inventors: Asya Rolls, Tamar Ben Shannan, Hilla Azulay-Debbie, Fahed Hakim, Maya Schiller, Shai Shen-Orr, Elina Starosvetsky
  • Publication number: 20160287577
    Abstract: A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.
    Type: Application
    Filed: November 26, 2014
    Publication date: October 6, 2016
    Inventors: Asya ROLLS, Tamar BEN SHANNAN, Hilla AZULAY-DEBBIE, Fahed HAKIM, Maya SCHILLER, Shai SHEN-ORR, Elina STAROSVETSKY
  • Publication number: 20070225251
    Abstract: Oligosaccharides, and in particular disaccharides, which are degradation products of chondroitin sulfate proteoglycan are effective for use in treating, inhibiting, or ameliorating the effects of injuries or diseases or disorders that result in or are caused by neuronal degeneration or of disorders resulting in mental and cognitive dysfunction.
    Type: Application
    Filed: September 8, 2004
    Publication date: September 27, 2007
    Inventors: Michal Eisenbach-Schwartz, Ofer Lider, Asya Rolls, Liora Cahalon
  • Publication number: 20070010484
    Abstract: Oligosaccharides, and in particular disaccharides, which are degradation products of chondroitin sulfate proteoglycan are effective for use in treating, inhibiting, or ameliorating the effects of injuries or diseases or disorders that result in or are caused by neuronal degeneration or of disorders resulting in mental and cognitive dysfunction. They are also useful for promoting neurogenesis.
    Type: Application
    Filed: June 23, 2006
    Publication date: January 11, 2007
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Michal Schwartz, Ofer Lider, Asya Rolls, Liora Cahalon, Osnat Lider